BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15062362)

  • 1. Carcinoma of the oral pharynx: an analysis of subsite treatment heterogeneity.
    Osborne RF; Brown JJ
    Surg Oncol Clin N Am; 2004 Jan; 13(1):71-80. PubMed ID: 15062362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
    Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Head and neck cancer: choice of treatment in relation to clinical and pathological findings].
    Ono I
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):18-23. PubMed ID: 3942398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On cervical lymph node metastasizing of malignant tumors with special reference to unknown primary tumors].
    Stricker G
    Monatsschr Ohrenheilkd Laryngorhinol; 1969; 103(4):174-82. PubMed ID: 5783323
    [No Abstract]   [Full Text] [Related]  

  • 7. Squamous cell carcinoma of the head and neck.
    Duvall AJ; Adams GL; Pollak K; Charyulu K
    Minn Med; 1973 Jun; 56(6):480-91. PubMed ID: 4710970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent progress in the treatment of oral and pharyngeal cancer].
    Uchida M; Nigauri T; Shimada S; Inoue A
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2070-6. PubMed ID: 1888178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging.
    Spiro RH; Alfonso AE; Farr HW; Strong EW
    Am J Surg; 1974 Oct; 128(4):562-7. PubMed ID: 4421032
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].
    Zbären P
    Ther Umsch; 1998 Jul; 55(7):449-52. PubMed ID: 9702117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological presentation of tongue cancers and early cancer treatment.
    Najeeb T
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cavity and oropharynx tumors.
    Stambuk HE; Karimi S; Lee N; Patel SG
    Radiol Clin North Am; 2007 Jan; 45(1):1-20. PubMed ID: 17157621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth.
    Pimenta Amaral TM; Da Silva Freire AR; Carvalho AL; Pinto CA; Kowalski LP
    Oral Oncol; 2004 Sep; 40(8):780-6. PubMed ID: 15288831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
    Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
    Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral.
    Northrop M; Fletcher GH; Jesse RH; Lindberg RD
    Cancer; 1972 Jan; 29(1):23-30. PubMed ID: 5007385
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervical lymph node metastases of cancer of unknown location].
    Vagner RI; Valdina EA; Mushkovskaia IuI
    Vopr Onkol; 1972; 18(2):9-13. PubMed ID: 5012927
    [No Abstract]   [Full Text] [Related]  

  • 19. Definitive radiation therapy for squamous cell carcinoma of the soft palate.
    Chera BS; Amdur RJ; Hinerman RW; Morris CG; Villaret DB; Werning JW; Mendenhall WM
    Head Neck; 2008 Aug; 30(8):1114-9. PubMed ID: 18615732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.